AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Midazolam Hydrochloride Equivalent To Midazolam

9 registrations across 1 African market— 4 active

Markets with Midazolam Hydrochloride Equivalent To Midazolam

🇿🇦South Africa
9 registrations
4 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
MIDANIUM 50 mg/10 ml🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
MILOZ 5🇿🇦South AfricaGulf Drug Company (Pty) LtdsuspendedSept 2024
MILOZ 15🇿🇦South AfricaGulf Drug Company (Pty) LtdsuspendedSept 2024
MIDAZOLAM - SAFELINE 15 mg🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedFeb 2024
MIDAZOLAM - SAFELINE 50 mg🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedFeb 2024
PHARMA-Q MIDAZOLAM INJECTION 5 mg/5 ml🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
PHARMA-Q MIDAZOLAM INJECTION 15 mg/3 ml🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
SPEC MIDAZOLAM🇿🇦South AfricaSpecpharm (Pty) LtdactiveJan 1900
PHARMA-Q MIDAZOLAM INJECTION 50 mg/10 ml🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900

Midazolam Hydrochloride Equivalent To Midazolam in Africa — Regulatory Overview

Midazolam Hydrochloride Equivalent To Midazolam is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 4 (44%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.